Search
for
Sort by
Research 511–540 of 1000+
- Pharmacological evidences for the extracts and secondary metabolites from plants of the genus Hibiscus
- Drug-Induced Skin, Nail and Hair Disorders
- The management of very low-calorie ketogenic diet in obesity outpatient clinic: a practical guide
- Tinea Capitis: An Overview with Emphasis on Management
- Dermatologic manifestations of endocrine disorders
- Adverse effects of common medications on male fertility
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Repurposing of approved cardiovascular drugs
- Safety of dermatologic medications in pregnancy and lactation
- Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: Current Knowledge and Future Perspectives
- Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Crafting Polymeric and Peptidic Hydrogels for Improved Wound Healing
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Induced Pluripotent Stem Cells from Human Hair Follicle Mesenchymal Stem Cells
- Serum Ferritin and Vitamin D in Female Hair Loss: Do They Play a Role?
- Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
- Cyclosporin A-induced hair growth in mice is associated with inhibition of calcineurin-dependent activation of NFAT in follicular keratinocytes
- Absorption sites of orally administered drugs in the small intestine
- Adverse Reactions to Oral Retinoids An Update
- Compliance With Contraceptives and Other Treatments
- Oral Manifestations of Hematologic and Nutritional Diseases
- Gender aspects in skin diseases
- Cutaneous Manifestations of Eating Disorders
- <i>Acorus calamus</i>: a bio-reserve of medicinal values
- Cinnamomi Cortex (Cinnamomum verum) Suppresses Testosterone-induced Benign Prostatic Hyperplasia by Regulating 5α-reductase
- Androgens and Antiandrogens
- Diet in dermatology: Revisited
- Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects